- Benchmark ASINB0FDXXJT66
- MarketplaceUS
- Category ID3760911
- Analyzed Products
- Keywordspicule serum, microneedle serum, pdrn serum, exosome serum, liposome serum, ampoule
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-30
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不值得进入，已经是拥挤且明显向价格战收缩的赛道。 虽然单个新品的入场预算门槛不高，但新品牌成功率只有39.13%，新品牌新品失败率高达60.87%，而且近几个月新品里几乎看不到稳定扩张的迹象，继续推进只会更依赖投放和品牌势能。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很直接：这个市场不适合进入。 你有50万人民币，单个新品的入场资金是够的，但市场已经明显过热：新品牌有22个，新发布产品46个，且新品牌新品盈利率只有34.38%，非盈利率高达56.25%，这不是可复制的好机会，而是竞争已经把失败率抬高的市场。
Early sourcing + logistics + marketing budget (USD)$1,334.18 - $19,205.19Explains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?30.43%New listing success rate (old brands):50.00%New listing success rate (new brands):34.38%Which new brands have these successful new listings?...Which old brands have these successful new listings?...Alternatives- 高保湿基础精华/安瓶：以甘油、透明质酸、泛醇为主的入门补水精华，价格通常更低、刺激性更小，适合替代偏功效型的PDRN/外泌体/微针概念产品。
- 神经酰胺修护乳/面霜：如果用户购买这类产品主要是为了屏障修护、干燥和稳定肤感，修护面霜往往更直观、更容易坚持使用，也更适合敏感或懒人护肤场景。
- 烟酰胺控油提亮精华：想要替代“肤质变好、细腻、提亮”的诉求时，烟酰胺产品通常更普及、价格更亲民，且选择更多。
- 积雪草/泛醇舒缓精华：若用户关注的是泛红、刺痒、术后舒缓或日常维稳，传统舒缓型精华比PDRN、外泌体、脂质体高概念产品更容易接受。
- 胜肽类精华：针对轻度细纹、弹润和紧致诉求，基础胜肽产品通常比“胶原/视黄醛/复合囊泡”方案更温和，适合不想用强功效活性的人。
- 维A替代入门方案：低浓度视黄醇或视黄醛霜/乳，而不是高概念复合胶囊精华；若目标是纹理和细纹管理，这类产品通常更成熟、性价比更高。
- 医美/诊所级低频方案：如果用户真正追求‘微针、PDRN、外泌体’这类结果导向，偶尔做一次基础皮肤管理或微针项目，有时比长期购买高价精华更直接；但需要看当地可及性和预算。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不适合进入：虽然表面上看新产品利润率不低，但新品牌与旧品牌都在高频进入，且新品牌新上架成功率只有34.38%，失败率56.25%，说明竞争已经很挤，继续做大概率会被价格和投放成本压住。 对小商家来说，只有极少数真正跑出来的低成本案例能看，不能把老品牌的成功当成自己的模板；对大品牌来说，能做，但必须靠明显的品牌势能和更高预算去抢，不是稳健机会。
New products with Highest revenueGOODAL
Recent Monthly Revenue (USD):$84,040.00(4000pcs/month)B0GGGCV238 (4.6/5 (95 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsmedicube
Recent Monthly Revenue (USD):$1,125,600.00(60000pcs/month)B0DBF65JYY (4.7/5 (19015 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitable
Recent Monthly Revenue (USD):$187,600.00(10000pcs/month)B0DCJ7952P (4.7/5 (4037 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableRecent Monthly Revenue (USD):$171,720.00(9000pcs/month)B0FR4QYNK5 (4.7/5 (768 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableLeast investment in new productsSKSOYT
Recent Monthly Revenue (USD):$9,124.50(550pcs/month)B0GHY29YHR (4.4/5 (17 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (USD):$8,624.00(550pcs/month)B0FNRLBW86 (4.3/5 (69 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQBlack HatThis listing is deemed profitableMost investment in new productsRE:CIPE
Recent Monthly Revenue (USD):-(-)B0GN4SWMZ2Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$8,885.00(500pcs/month)B0GL83SVTW (4.2/5 (30 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQLeast profitable new productsGASHINA STORY
Recent Monthly Revenue (USD):-(-)B0FSQK3WY7 (4/5 (3 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (USD):-(-)B0FSQZYT7K (4/5 (3 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):-(-)B0FSQK7M27Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 喷雾精华二合一，形态最特别。
- |
- 粉色瓶身，视觉冲击强，容易被点开。
- |
- 适合通勤/运动后快速补水，场景明确。
B0FYN9CJKC (4.6/5 (1849 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 2ml棒状分装，和常规精华差异最大。
- |
- 微针感+一次用量，功能卖点很直观。
- |
- 小包装便携，适合尝鲜型用户点击。
B0FSQK3WY7 (4/5 (3 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不建议进入：新品利润集中在20%~40%，但真正可复制的机会几乎都被老品牌和头部大牌吃掉了；新品牌有利润的比例约34.38%，但新品牌新品不赚钱的比例更高，约56.25%，这说明“能活下来”的多是强品牌或重营销，而不是普通小卖家。 你的预算500000元看起来充足，但市场不是钱不够，而是进入后很容易被压进同质化竞争里，尤其近一年新品中不赚钱的数量已经明显偏多，属于竞争升温、机会在变窄的市场。
Profitability difficultyPotential high net profit marginAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0DBF65JYYmedicube2024-10-04Yes$18.7660000pcs$1125600.032.48%$365594.88B0DCJ7952Pmedicube2024-08-08Yes$18.7610000pcs$187600.028.98%$54366.48B0FR4QYNK5medicube2025-09-15Yes$19.089000pcs$171720.028.82%$49489.71
B0D137TMRBmedicube2024-04-07Yes$19.866000pcs$119160.032.03%$38166.95B0FYN9CJKCmedicube2025-10-31Yes$14.4510000pcs$144500.023.99%$34665.55B0G29RKZ1Hmedicube2025-11-14Yes$17.287000pcs$120960.026.46%$32006.02B0GGGCV238GOODAL2026-01-13Yes$21.014000pcs$84040.030.48%$25615.4B0DQCLFJCBmedicube2024-12-13Yes$21.173000pcs$63510.033.51%$21282.21
B0CP3C7TTJK-SECRET2023-11-28Yes$17.693000pcs$53070.030.24%$16048.37
B0GTXV3BY2Beauty of Joseon2026-03-26Yes$17.383000pcs$52140.029.43%$15344.81
B0DXV9WQ7Lmedicube2025-02-20Yes$18.323000pcs$54960.027.9%$15333.85
B0DRNYBX1Tmedicube2024-12-27Yes$17.332000pcs$34660.033.0%$11437.8
B07ZKHPV9YSKIN10042019-10-25Yes$12.564000pcs$50240.020.94%$10520.26B0BTRWGQNVSKIN10042023-02-03Yes$14.063000pcs$42180.020.67%$8718.61
B0GQ9PPV61SKIN10042026-02-26Yes$16.72000pcs$33400.025.16%$8403.44
B0H2Q7FYZNmixsoon2026-05-25Yes$21.011000pcs$21010.032.87%$6905.99
B0F4QRGK2NVT COSMETICS2025-04-14Yes$20.851000pcs$20850.033.09%$6899.27
B0CPY3Y418VT COSMETICS2023-12-11Yes$19.551000pcs$19550.032.86%$6424.13
B0FSJ7CQY6ANUA2025-01-10Yes$18.01000pcs$18000.033.47%$6024.6
B0DQCJ9T9Nmedicube2024-12-13Yes$19.171000pcs$19170.031.36%$6011.72Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FR4QYNK5medicube2025-09-15Yes$19.089000pcs$171720.028.82%$49489.71B0FYN9CJKCmedicube2025-10-31Yes$14.4510000pcs$144500.023.99%$34665.55B0G29RKZ1Hmedicube2025-11-14Yes$17.287000pcs$120960.026.46%$32006.02B0GGGCV238GOODAL2026-01-13Yes$21.014000pcs$84040.030.48%$25615.4B0GTXV3BY2Beauty of Joseon2026-03-26Yes$17.383000pcs$52140.029.43%$15344.81B0GQ9PPV61SKIN10042026-02-26Yes$16.72000pcs$33400.025.16%$8403.44B0H2Q7FYZNmixsoon2026-05-25Yes$21.011000pcs$21010.032.87%$6905.99
B0FMXQBQLXDr.Althea2025-08-19Yes$17.76900pcs$15984.026.88%$4296.5
B0GJ332LJHKuri Nuka2026-01-22Yes$19.97700pcs$13979.030.03%$4197.9B0GHY29YHRSKSOYT2026-03-29Yes$16.59550pcs$9124.524.57%$2241.89B0FNRLBW86SKSOYT2025-10-19Yes$15.68550pcs$8624.023.9%$2061.14
B0GK2HW2Z5Tree of Life2026-06-04Yes$15.28400pcs$6112.029.01%$1773.1B0FDXXJT66SKIN10042025-08-13Yes$12.35700pcs$8645.020.41%$1764.45
B0GMKBWV7LNIDA2026-02-09Yes$15.49400pcs$6196.026.32%$1630.79
B0FKMKZGSGMEDIHEAL2025-07-31Yes$16.75300pcs$5025.028.48%$1431.12
B0FMFBGW9NCELDYQUE2025-09-26Yes$18.22100pcs$1822.029.63%$539.86
B0G2CKD7M9MAREE2025-12-20Yes$9.84400pcs$3936.011.32%$445.56
B0FRKCFLBRDr.nineteen2025-09-18Yes$23.1850pcs$1159.033.05%$383.05#New Product Success Rates
Listing这个市场不适合进入，已经接近价格战和品牌挤压区，不论大品牌还是小商家，都不应继续推进。 关键原因很直接：新品牌新品成功率只有 37.93%，失败率 62.07%；整体新品成功率 38.10%，但真正能被认可的盈利新品并不集中在新入局者身上，而是被老牌和强势品牌拿走了大头。
证据很明确：头部盈利几乎被老牌控制，且很多新品牌在亏损。 旧品牌新品里，盈利集中在 medicube（3个盈利款）、SKIN1004（2个）、MEDIHEAL（1个）、CELDYQUE（1个）；而亏损端也有 SKIN1004、medicube、WELLDERMA、CELDYQUE、WELLAGE、SKIN DEVA 等老牌在内，说明连强品牌都要持续烧钱竞争。具体到可落地的案例，SKIN1004 的 B0FDXXJT66 仍能做到 20.4% 利润率、月销 700、月营收约 8645美元，但它的早期投入约 12038.29美元，这不是轻量试错，而是带品牌力和投放能力的打法；medicube 的 B0FYN9CJKC 更强，月销 10000、月营收约 14450000（按数据口径），并且它本身是成熟老牌，不是小商家的可复制模板。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
SKIN1004medicubeSKSOYTOtherNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
GASHINA STORYOther#Success Rate by Entry Time
Listing这个市场不值得进入，已经接近/进入过度拥挤状态，而且最近新品竞争正在明显加剧。 近一年新品成功率只有39.13%，但最近月份里盈利新品明显变少，2026/4全是亏损新品，2026/5与2026/6也只是零星盈利，说明不是“还能轻松做”的市场，而是越来越难做、越来越靠品牌和营销硬推的市场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 1 8 1 0 10 2026 0 0 0 0 5 3 0 18 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 1 0 0 0 2025/8 0 0 0 0 2 0 0 1 2025/9 0 0 0 0 2 1 0 5 2025/10 0 0 0 0 2 0 0 1 2025/11 0 0 0 0 1 0 0 0 2025/12 0 0 0 1 0 0 0 3 2026/1 0 0 0 0 0 2 0 2 2026/2 0 0 0 0 2 0 0 3 2026/3 0 0 0 0 2 0 0 2 2026/4 0 0 0 0 0 0 0 4 2026/5 0 0 0 0 0 1 0 2 2026/6 0 0 0 0 1 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases
Anua Heartleaf 80 Soothing Ampoule, Hydrating Facial Serum for Glass Skin, Hyaluronic Acid, Panthenol, Lightweight, Non-Greasy Formula, Korean Skincare, 1.01 fl.oz
This listing is deemed profitablePrice (USD)$21.95Released TypeOld Release (2020-07-09)Brand is an old entry in this marketSize and Weight10.5 x 4.6 x 4.5 cm, 141.00gProfitable Factors
Established brand with longevityBased on old ASINDesign & Appearance
浅琥珀色精华液，视觉上偏温和、自然, 滴管式安瓶瓶身，典型韩系护肤安瓶形态，非私模独占外观Key Buying Motive
80%鱼腥草主打舒缓保湿，叠加玻尿酸和泛醇，定位更偏日常温和修护Target Customers
偏好温和、无香、适合早晚高频使用的敏感肌/泛红肌人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$13,170.00600 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight30.40% / 31.75%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight27.27% / 28.62%Peak / Non PeakSales & BSR Performance
medicube Exosome Shot PDRN Pink Collagen 2,000 PPM Spicule Facial Serum
This listing is deemed profitablePrice (USD)$19.17Released TypeOld Release (2024-12-13)Brand is an old entry in this marketSize and Weight10.6 x 4.2 x 4.1 cm, 45.00gProfitable Factors
Established brand with longevityDistinct functions and featuresBased on old ASINDesign & Appearance
粉色渐变瓶身，整体更偏“修护美容院感”视觉，和常见透明/白色精华区分明显。, 泵瓶式精华包装，瓶身细长简洁，强调高级感与日常护肤便利性。Key Buying Motive
以Exosome-coated Spicules、2,000 PPM微针刺激感、PDRN、胶原、烟酰胺组合，主打“吸收效率+提亮修护+弹润”一体化。Target Customers
更适合追求微针刺感、希望在家做高效导入与肌肤焕活的韩系功效护肤用户。Early Investment
Investment
Monthly Revenue (Recent) (USD)$19,170.001000 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight29.95% / 31.36%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight28.80% / 30.22%Peak / Non PeakSales & BSR Performance
Loading samples... 10%